Cargando…

Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis

Detalles Bibliográficos
Autores principales:	Dhar, Sujan K., Sachdeva, Kartik, Das, Manjula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903900/ https://www.ncbi.nlm.nih.gov/pubmed/33676871 http://dx.doi.org/10.1016/j.dsx.2021.02.021

Ejemplares similares

Value of thromboelastography in managing hypercoagulopathy in intensive care
por: Aron, J, et al.
Publicado: (2015)

Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry
por: Iwasaki, Yudai, et al.
Publicado: (2020)

Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy
por: Song, Jing-Chun, et al.
Publicado: (2021)

IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression
por: Dhar, Sujan K., et al.
Publicado: (2021)

Serial rotational thromboelastography (ROTEM) in mechanically ventilated patients with COVID-19 demonstrates hypercoagulopathy despite therapeutic heparinization
por: Choi, James K, et al.
Publicado: (2022)

Hypercoagulopathy as a severe Long-term complication of post SARS-CoV-19 infection
por: Zhang, Xinhai R., et al.
Publicado: (2022)

Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
por: Pasquarelli-do-Nascimento, Gabriel, et al.
Publicado: (2020)

Relative quantification of BCL2 mRNA for diagnostic usage needs stable uncontrolled genes as reference
por: Dwivedi, Nehanjali, et al.
Publicado: (2020)

Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients
por: Gedefaw, Lealem, et al.
Publicado: (2021)

Hypercoagulopathy in Overweight and Obese COVID-19 Patients: a Single-Center Case Series
por: Sarfraz, Azza, et al.
Publicado: (2021)

Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic
por: Ono, Yuko, et al.
Publicado: (2017)

Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study
por: Pourafkari, Leili, et al.
Publicado: (2021)

Nephrotic syndrome‐associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors
por: Waller, Amanda P., et al.
Publicado: (2020)

Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report
por: Asmarawati, Tri Pudy, et al.
Publicado: (2022)

Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature
por: Sachdeva, Sonali, et al.
Publicado: (2020)

Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report
por: Garg, Akash, et al.
Publicado: (2021)

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome
por: Simeoli, Chiara, et al.
Publicado: (2023)

Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation
por: van der Linden, Jan, et al.
Publicado: (2020)

Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients
por: Dwivedi, Nehanjali, et al.
Publicado: (2023)

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome
por: Edström, Dag, et al.
Publicado: (2023)

The association of oxidative stress biomarkers with type 2 diabetes mellitus: A systematic review and meta‐analysis
por: Banik, Sujan, et al.
Publicado: (2021)

Male non-insulin users with type 2 diabetes mellitus are predisposed to gastric corpus-predominant inflammation after H. pylori infection
por: Yang, Yao-Jong, et al.
Publicado: (2017)

Evaluation of predominant risk factors for type 2 diabetes mellitus among out-patients in two Nigerian secondary health facilities
por: Iheanacho, Chinonyerem O, et al.
Publicado: (2021)

Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus
por: Colaiori, Iginio, et al.
Publicado: (2019)

Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study
por: Fan, Yen-Chun, et al.
Publicado: (2017)

Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary)
por: Hossain, Mohammad Delwar, et al.
Publicado: (2016)

Is diabetes mellitus a wrongdoer to COVID-19 severity?
por: Sarkar, Sanjib, et al.
Publicado: (2021)

Diabetes is predominantly an intestinal disease
por: Sanyal, Debmalya
Publicado: (2013)

Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus
por: Ellulu, Mohammed S., et al.
Publicado: (2022)

Diabetes mellitus and the risk of glioma: a meta-analysis
por: Zhao, Luqian, et al.
Publicado: (2015)

Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis
por: Li, Junshan, et al.
Publicado: (2015)

Exercise Improves Glycemic Control Among Patients with Type 2 Diabetes Mellitus: A Summary of Meta-analysis and Systematic Reviews
por: Okechukwu, Chidiebere Emmanuel
Publicado: (2019)

Genome wide search to identify reference genes candidates for gene expression analysis in Gossypium hirsutum
por: Smitha, P. K., et al.
Publicado: (2019)

Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
por: Yun, Jae-Seung, et al.
Publicado: (2016)

Periodontal Therapy and Systemic Inflammation in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Artese, Hilana Paula Carillo, et al.
Publicado: (2015)

Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients
por: Tsur, Noa, et al.
Publicado: (2019)

Risk factors of amyotrophic lateral sclerosis: a global meta-summary
por: Duan, Qing-Qing, et al.
Publicado: (2023)

Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation
por: Bathina, Siresha, et al.
Publicado: (2021)

Decreased severity of COVID‐19 in vaccinated pregnant individuals during predominance of different SARS‐CoV‐2 variants
por: Eid, Joe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kdaoru9b7hv0rt5k2mdjn846m